XOSTEM

XOStem is the stem cell expert that creates the next generation treatment for Type 1 Diabetes and produces Engineered Exosomes. XO Engineered Exosomes and therapy for type1 diabetics are their first products being readied for the market. They have follow-on plans for each one of these initial 2 products. As an example, the Macrodevice used to house insulin-producing cells in their type1 diabetes device will also be used as a delivery vehicle in other therapies in the future. The company was founded in 2018 and is headquartered in Irvine, California.